As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >


Campus 3 – Building 5 – 1, rue Pierre Fontaine
91058 EVRY Cedex – FRANCE
Phone: +33 1 60 91 33 10

Eric HENRIET: Deputy CEO
Site Web >
Texcell - Genopole's Company Texcell - Genopole's Company

#Biomanufacturing / Pharmaceutical Services

  • Viral safety testing
  • Viral and prion validation
  • Immunomonitoring
  • Immunoprofiling
  • Healthcare

Field of Activity

Texcell offers fully GLP- and GMP-compliant viral safety testing and immunomonitoring services.

Texcell is a service company offering GLP- and GMP-compliant viral safety testing and immunology services.

With over 20 years of experience in the performance of biosafety and viral validation tests, Texcell has evaluated a large number of products – including some that have received marketing approval from the FDA, the EMEA and the MHW.
The company’s expertise is acknowledged worldwide and (since 2006) and it has developed commercial relationships with representatives based in Japan, India and South Korea. In 2010, Texcell has taken the majority in a company based in Middletown (Maryland) renamed Texcell North America.
Texcell offers a full catalogue of assays for the characterization of cell banks, the batch release of cellderived biotechnological products and viral validation studies for evaluating the ability of industrial process steps to eliminate and/or inactivate viruses (over 30 relevant or model viruses are available) and prions.

Texcell acts both as a contract service organization (CSO) and a central lab for preclinical and clinical trials. Texcell offers an immunology-dedicated technology platform with an exhaustive range of GLP assay development services (optimization and validation) for analyzing the immune response to humoral and/or cell-based mediation.

Today’s compound development timelines have to be as short as possible. Viral safety testing, viral validation studies and clinical studies must be continually improved, in order to optimize the therapeutic strategy. The company acts as a true partner for its customers and the staff is committed to offering the right experimental protocols and tools.

  • Further Information

    Annual turnover: €8M (world)
    72 staff members
    an international service company that is responsive and has a close relationship with its customers. Expertise in virology and immunology.
    Innovation assets:
    A specialist in viral and prion safety.
    Other facts:
    As an expert provider in virology, Texcell evaluates the viral safety of recombinant proteins, monoclonal antibodies, medical devices and other products of animal or human origin (such as blood-derived products, heparins, hyaluronic acid and collagens). The company also has expertise in immunomonitoring. Texcell develops and validates assays that monitor the immune response to cell based and/ or humoral mediation in clinical trials (ELISA, flow cytometry, Elispot: neutralizing serums, hemagglutination inhibition assays, bioassays, MSD).

Genopole’s Companies

#Biomanufacturing / Pharmaceutical Services

In same field

Alt Biotech - Genopole's Company Gene.iO#3

Alt Biotech

Alt Biotech offers an innovative bioproduction platform for non-therapeutic recombinant proteins: productive, scalable, with low environmental impact

Kyron.Bio - Genopole's Company


Kyron.Bio is a biotech company using synthetic biology to produce new therapies with high yield, activity, and stability standards.

Nutropy - Genopole's company


Nutropy develops gourmet French cheese alternatives that are more sustainable and better for our health and animal welfare.

STH Biotech - Genopole's company

STH Biotech

STH BIOTECH is developing an innovative cannabis-based process for the reliable and sustainable production of active compounds for the well-being and healthcare sectors.

Synovance - entreprise généopolitaine


Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.

Altar - entreprise génopolitaine - intégre le groupe Ginko Bioworks


Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Yposkesi - Genopole's Company


YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Watchfrog Laboratory - Genopole's company


WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services proposes fee-for-services R&D support and provides innovative technological platforms for i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and ii) selection and validation of VHH antibodies.

Genosafe - Genopole's Company


GenoSafe is a full contract research and consulting organization specialized in evaluating the quality, safety and efficacy of innovative biological products. Our goal is to enable our clients to move their products along clinical development rapidly and efficiently.

ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.

View all >
With the support from
Région île de France